AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BIO-GENE TECHNOLOGY LTD

0.031

0.000

Volume:- -

Turnover:- -

Market Cap:9.46M

PE:-2.53

High:0.031

Open:0.031

Low:0.031

Close:0.031

52wk High:0.061

52wk Low:0.016

Shares:305.06M

Float Shares:168.12M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.012

EPS(LYR):-0.012

ROE:-116.99%

ROA:-61.77%

PB:5.81

PE(LYR):-2.53

Loading ...

Overview Company News Filings

BRIEF-Bio-Gene Technology Appoints Drew Speedy As CFO

Bio-Gene Technology Ltd-CFO and Company Secretary Appointment/Resignation

THOMSON REUTERS

Bio-Gene Technology Ltd-U.S. Department of Defense Grant Programs Advance

THOMSON REUTERS

Insider Stock Buying Of Bio-Gene Technology Delivers Return On AU$815.0k Investment

Simply Wall St.

Bio-Gene Technology Says Qcide Receives Organic Listing Status In USA

Bio-Gene Technology Ltd-Chair's Address to Shareholders

THOMSON REUTERS

ASX Small-Cap Stocks to Watch

MT Newswires Live

BRIEF-Bio-Gene Technology Says Qcide Receives Organic Listing Status In USA

Bio-Gene Technology Ltd-Qcide Receives Organic Listing Status in USA

THOMSON REUTERS

Bio-Gene Technology Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS

Bio-Gene Technology Ltd-Review of Continuous Disclosure Procedures

THOMSON REUTERS

ASX Biggest Gainers

MT Newswires Live

Bio-Gene Reports Strong Flavocide Results Against Ticks to Leading US Lyme Disease Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BGT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BGT.AU\",,,,,undefined,":{"symbol":"BGT.AU","market":"AU","secType":"STK","nameCN":"BIO-GENE TECHNOLOGY LTD","latestPrice":0.031,"timestamp":1770959520000,"preClose":0.031,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"BIO-GENE TECHNOLOGY LTD","floatShares":168118597,"shares":305061108,"eps":-0.012234,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:12:00 AEDT","open":0.031,"high":0.031,"low":0.031,"amount":0,"amplitude":0,"askPrice":0.033,"askSize":10000,"bidPrice":0.031,"bidSize":231128,"shortable":3,"etf":0,"ttmEps":-0.012234,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.031,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BGT.AU\",,,,,undefined,":{"symbol":"BGT.AU","floatShares":168118597,"roa":"-61.77%","roe":"-116.99%","lyrEps":-0.012234,"shares":305061108,"dividePrice":0,"high":0.031,"amplitude":0,"preClose":0.031,"low":0.031,"week52Low":0.016,"pbRate":"5.81","psRate":"-21739.99","week52High":0.061,"institutionHeld":0,"latestPrice":0.031,"committee":0.917057,"eps":-0.012234,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.012234,"open":0.031,"prevYearClose":0.023,"prevWeekClose":0.033,"prevMonthClose":0.035,"prevQuarterClose":0.023,"fiveDayClose":0.033,"twentyDayClose":0.026,"sixtyDayClose":0.028},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGT.AU\",params:#limit:5,,,undefined,":[{"date":"2023-04-27","symbol":"BGT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682553600000,"name":null,"time":"","dateTimestamp":1682517600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608838087","title":"BRIEF-Bio-Gene Technology Appoints Drew Speedy As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2608838087","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608838087?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:38","pubTimestamp":1769996315,"startTime":"0","endTime":"0","summary":"BRIEF-Bio-Gene Technology Appoints Drew Speedy As CFOFeb 2 (Reuters) - Bio-Gene Technology BGT.AX:CFO AND COMPANY SECRETARY APPOINTMENT/RESIGNATIONAPPOINTS DREW SPEEDY AS CFOFurther company coverage: BGT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUE2305VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGT.AU","BK7020"],"gpt_icon":0},{"id":"2608884468","title":"Bio-Gene Technology Ltd-CFO and Company Secretary Appointment/Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608884468?lang=en_us&edition=fundamental","pubTime":"2026-02-02 06:11","pubTimestamp":1769983906,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nTUE2305VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7020","BGT.AU"],"gpt_icon":0},{"id":"2592945782","title":"Bio-Gene Technology Ltd-U.S. Department of Defense Grant Programs Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2592945782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592945782?lang=en_us&edition=fundamental","pubTime":"2025-12-18 05:54","pubTimestamp":1766008443,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUE3HQJZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BGT.AU","BK7020"],"gpt_icon":0},{"id":"2588067750","title":"Insider Stock Buying Of Bio-Gene Technology Delivers Return On AU$815.0k Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2588067750","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588067750?lang=en_us&edition=fundamental","pubTime":"2025-12-03 04:26","pubTimestamp":1764707215,"startTime":"0","endTime":"0","summary":"Insiders who bought Bio-Gene Technology Limited ( ASX:BGT ) stock lover the last 12 months are probably not as affected...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice2-main-header/1585186853880","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice2-main-header/1585186853880"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-bgt/bio-gene-technology-shares/news/insider-stock-buying-of-bio-gene-technology-delivers-return","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-bgt/bio-gene-technology-shares/news/insider-stock-buying-of-bio-gene-technology-delivers-return","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BGT.AU","BK7020"],"gpt_icon":0},{"id":"2584922992","title":"Bio-Gene Technology Says Qcide Receives Organic Listing Status In USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2584922992","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584922992?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:41","pubTimestamp":1763574106,"startTime":"0","endTime":"0","summary":"Nov 14 (Reuters) - Bio-Gene Technology ::*QCIDE RECEIVES ORGANIC LISTING STATUS IN USA*Further company coverage: BGT.AX* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202521:05:00.417 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDc3nFT4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGT.AU","BK7020"],"gpt_icon":0},{"id":"2584899954","title":"Bio-Gene Technology Ltd-Chair's Address to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2584899954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584899954?lang=en_us&edition=fundamental","pubTime":"2025-11-19 11:18","pubTimestamp":1763522316,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUEBVG0S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7020","BGT.AU"],"gpt_icon":0},{"id":"2583545324","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2583545324","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583545324?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:46","pubTimestamp":1763077568,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Bio-Gene Technology (ASX:BGT)Bio-Gene Technology said the US Organic Materials Review","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GCmain","MGCmain","BK7104","DTZ.AU","RC1.AU","1OZmain","SGUmain","BGT.AU","IAU","MGU.AU","GDX","BK7076","518880","NUGT","159934","SGCmain","BK7020","DUST","BK7095","HMG.AU","BK7506"],"gpt_icon":1},{"id":"2583512556","title":"BRIEF-Bio-Gene Technology Says Qcide Receives Organic Listing Status In USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512556","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512556?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:20","pubTimestamp":1763068820,"startTime":"0","endTime":"0","summary":"BRIEF-Bio-Gene Technology Says Qcide Receives Organic Listing Status In USANov 14 (Reuters) - Bio-Gene Technology BGT.AX:QCIDE RECEIVES ORGANIC LISTING STATUS IN USAFurther company coverage: BGT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUE86H5LX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7020","BGT.AU"],"gpt_icon":0},{"id":"2583514074","title":"Bio-Gene Technology Ltd-Qcide Receives Organic Listing Status in USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514074?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:19","pubTimestamp":1763068760,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUE86H5LX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7020","BGT.AU"],"gpt_icon":0},{"id":"2579103514","title":"Bio-Gene Technology Ltd-Quarterly Activities/Appendix 4C Cash Flow Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2579103514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579103514?lang=en_us&edition=fundamental","pubTime":"2025-10-31 05:17","pubTimestamp":1761859054,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE3PCSP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7020","BGT.AU"],"gpt_icon":0},{"id":"2577634701","title":"Bio-Gene Technology Ltd-Review of Continuous Disclosure Procedures","url":"https://stock-news.laohu8.com/highlight/detail?id=2577634701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577634701?lang=en_us&edition=fundamental","pubTime":"2025-10-23 10:44","pubTimestamp":1761187465,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUE35XCMY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BGT.AU","BK7020"],"gpt_icon":0},{"id":"2569697761","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2569697761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569697761?lang=en_us&edition=fundamental","pubTime":"2025-09-23 14:04","pubTimestamp":1758607496,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Tuesday.Everlast Minerals : +43%, AU$0.285HYDRIX : +38%, AU$0.018Bio-Gene Technology : +35%, AU$0.042Terra Uranium : +32%, AU$0.083Iltani Resources : +25%, AU$0.42Enegetx : +25%, AU$0.03Caprice Resources : +23%, AU$0.123Brazilian Critical Minerals : +22%, AU$0.033Podium Minerals : +22%, AU$0.066Thunderbird Resources : +21%, AU$0.023","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7084","ILT.AU","THB.AU","T92.AU","BK7104","HYD.AU","BK7020","CRS.AU","POD.AU","BGT.AU","EV8.AU","BK7095","BCM.AU","ENX.AU","BK7083"],"gpt_icon":0},{"id":"2569757671","title":"Bio-Gene Reports Strong Flavocide Results Against Ticks to Leading US Lyme Disease Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2569757671","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569757671?lang=en_us&edition=fundamental","pubTime":"2025-09-23 09:27","pubTimestamp":1758590855,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology  has released new data confirming that its lead compound Flavocide delivers strong activity against ticks responsible for spreading Lyme disease in the United States.Presented by Purdue University researchers at the International Conference on Lyme Borreliosis and Other Tick-Borne Diseases in Chicago, the findings showed that Flavocide achieved more than 90% mortality ofIxodes scapularis “deer” or “black-legged” tick nymphs within 24 hours.Importantly, the prototype formulation also displayed residual protection lasting up to four weeks, pointing to a durable solution that could support both public health programs and animal health markets.The Purdue team assessed Flavocide using a new “Phenocosm” assay that replicates natural environments such as mulch, turf, and leaf litter.By working under conditions that reflected real-world settings – ambient temperatures, moderate pH levels and no harsh additives – the trials demonstrated that the compound can perform strongly","market":"nz","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/BioGene-Technologies-ASX-BGT-Strong-Flavocide-Results-Ticks-US-Lyme-Disease-Conference.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/BioGene-Technologies-ASX-BGT-Strong-Flavocide-Results-Ticks-US-Lyme-Disease-Conference.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/bio-gene-reports-strong-flavocide-results-ticks-lyme-disease-us-conference/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/bio-gene-reports-strong-flavocide-results-ticks-lyme-disease-us-conference/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7020","BGT.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}